137 related articles for article (PubMed ID: 21406965)
1. DNA methylation analyses of the connexin gene family reveal silencing of GJC1 (Connexin45) by promoter hypermethylation in colorectal cancer.
Sirnes S; Honne H; Ahmed D; Danielsen SA; Rognum TO; Meling GI; Leithe E; Rivedal E; Lothe RA; Lind GE
Epigenetics; 2011 May; 6(5):602-9. PubMed ID: 21406965
[TBL] [Abstract][Full Text] [Related]
2. Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumors.
Ahmed D; Lothe RA; Rivedal E; Lind GE
Endocr Relat Cancer; 2011 Oct; 18(6):C31-4. PubMed ID: 21868474
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
Lind GE; Kleivi K; Meling GI; Teixeira MR; Thiis-Evensen E; Rognum TO; Lothe RA
Cell Oncol; 2006; 28(5-6):259-72. PubMed ID: 17167179
[TBL] [Abstract][Full Text] [Related]
4. Connexins in colorectal cancer pathogenesis.
Sirnes S; Lind GE; Bruun J; Fykerud TA; Mesnil M; Lothe RA; Rivedal E; Kolberg M; Leithe E
Int J Cancer; 2015 Jul; 137(1):1-11. PubMed ID: 24752574
[TBL] [Abstract][Full Text] [Related]
5. The expression of the tumor suppressor gene connexin 26 is not mediated by methylation in human esophageal cancer cells.
Loncarek J; Yamasaki H; Levillain P; Milinkevitch S; Mesnil M
Mol Carcinog; 2003 Feb; 36(2):74-81. PubMed ID: 12557263
[TBL] [Abstract][Full Text] [Related]
6. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
7. Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells.
Nishimura M; Saito T; Yamasaki H; Kudo R
Carcinogenesis; 2003 Oct; 24(10):1615-23. PubMed ID: 12896902
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
10. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.
Qi J; Zhu YQ; Luo J; Tao WH
World J Gastroenterol; 2006 Nov; 12(44):7113-7. PubMed ID: 17131472
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.
Yamasaki H; Omori Y; Zaidan-Dagli ML; Mironov N; Mesnil M; Krutovskikh V
Cancer Detect Prev; 1999; 23(4):273-9. PubMed ID: 10403898
[TBL] [Abstract][Full Text] [Related]
14. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
15. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
[TBL] [Abstract][Full Text] [Related]
16. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
17. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
[TBL] [Abstract][Full Text] [Related]
18. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.
Arnold CN; Goel A; Niedzwiecki D; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Oct; 3(10):960-4. PubMed ID: 15326380
[TBL] [Abstract][Full Text] [Related]
19. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
